Zika virus： a new threat from mosquitoes

In the winter of 2015,the first dengue vaccine（Dengvaxia）was approved for clinical use.Dengue virus is the most prevalent mosquito-transmitted viral pathogen in humans（Qin and Shi,2014）.Even though the approved Dengvaxia has its weaknesses（e.g.,low protection against serotype-2virus）,it has been rec...

Full description

Saved in:
Bibliographic Details
Published in:Science China. Life sciences 2016-04, Vol.59 (4), p.440-442
Main Authors: Li, Xiao-Feng, Han, Jian-Feng, Shi, Pei-Yong, Qin, Cheng-Feng
Format: Article
Language:English
Subjects:
Animals
Biomedical and Life Sciences
Culicidae - virology
Early Diagnosis
Epidemics - prevention & control
Humans
Insect Vectors - virology
Life Sciences
Mosquito Control - methods
News and Views
Zika Virus - physiology
Zika Virus Infection - diagnosis
Zika Virus Infection - epidemiology
Zika Virus Infection - virology
临床使用
墨西哥
威胁
病原体
病毒性
登革热
登革病毒
蚊子
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the winter of 2015,the first dengue vaccine（Dengvaxia）was approved for clinical use.Dengue virus is the most prevalent mosquito-transmitted viral pathogen in humans（Qin and Shi,2014）.Even though the approved Dengvaxia has its weaknesses（e.g.,low protection against serotype-2virus）,it has been recently licensed to Mexico,Philippines,
ISSN:1674-7305
1869-1889
DOI:10.1007/s11427-016-5020-y